Longevity science is on the brink of transforming public health and the global economy. My article examines how implementing targeted policy changes—such as increasing NIA funding, introducing tax incentives, and establishing an FDA Longevity Pathway—can position the U.S. as a global leader in longevity, reduce healthcare costs, and drive economic growth.